Andere Sprachen Repligen Corporation

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 01.05.2024			% 5 Tage	% 1. Jan.
158,4 ^USD	-3,56 %		-5,66 %	-11,92 %

08.04.	REPLIGEN CORPORATION : RBC Capital Markets behält seine Kaufempfehlung bei	ZM
20.03.	Transcript : Repligen Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 03:00 PM

Repligen's Q1 Adjusted Earnings, Revenue Fall	14:48
(RGEN) REPLIGEN CORPORATION Sees Fiscal Year 2024 EPS Range $1.42 - $1.49	13:49
Repligen: Q1 Earnings Snapshot	13:48
Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $151.3M, vs. Street Est of $150.1M	13:47
Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Adjusted Q1 EPS $0.28, vs. Street Est of $0.30	13:46
Repligen Reports First Quarter 2024 Financial Results	13:31
Repligen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	13:30
North American Morning Briefing : Traders Wait for -2-	12:13
Repligen to Report First Quarter 2024 Financial Results	17.04.
Repligen : Investor Presentation April 2024 Presentations	02.04.
Repligen Appoints Maggie A. Pax to Board of Directors	19.03.
Repligen Corporation Appoints Maggie A. Pax as Board of Directors	19.03.
Repligen Insider Sold Shares Worth $681,348, According to a Recent SEC Filing	13.03.
Repligen Insider Sold Shares Worth $3,298,632, According to a Recent SEC Filing	12.03.
Repligen Insider Sold Shares Worth $866,204, According to a Recent SEC Filing	27.02.
Sector Update: Health Care Stocks Flat to Lower Premarket Wednesday	21.02.
Sector Update: Health Care	21.02.
Repligen Q4 Adjusted Earnings, Revenue Decline; Issues 2024 Guidance; Shares Fall Premarket	21.02.
Sartorius fällt - Ausblick von Repligen enttäuscht	21.02.
Repligen: Q4 Earnings Snapshot	21.02.

Keine Ergebnisse zu dieser Suche